Professional
Added to YB: 2024-02-20
Pitch date: 2024-02-14
BAX [bullish]
Baxter International Inc.
-30.33%
current return
Author Info
No bio for this author
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$11.7B
Pitch Price
$37.91
Price Target
N/A
Dividend
0.18%
EV/EBITDA
9.50
P/E
-11.84
EV/Sales
1.71
Sector
Health Care Equipment and Supplies
Category
turnaround
Broyhill Asset Management Portfolio Holding - Baxter International
BAX -15% as Novo threatens Renal Care division. Margins <14% post-Hillrom deal, pandemic inflation. $12B spent, now $16B mkt cap. Selling BioPharma to cut debt, targeting <3x leverage by FY25. Renal spinoff, reporting overhaul to streamline ops. Low valuation on poor earnings, but $5 EPS rebound seen. Upcoming strategy moves & investor day catalysts.
Read full article (2 min)